Suppr超能文献

1990年至2021年尿毒症心肌病的文献计量学与可视化分析

A Bibliometric and Visualized Analysis of Uremic Cardiomyopathy From 1990 to 2021.

作者信息

Bao Jing-Fu, Hu Pan-Pan, She Qin-Ying, Zhang Difei, Mo Jia-Ju, Li Aiqing

机构信息

State Key Laboratory of Organ Failure Research, National Clinical Research Center for Kidney Disease, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Guangdong Provincial Key Laboratory of Renal Failure Research, Guangzhou Regenerative Medicine and Health Guangdong Laboratory, Guangzhou, China.

出版信息

Front Cardiovasc Med. 2022 Jul 12;9:908040. doi: 10.3389/fcvm.2022.908040. eCollection 2022.

Abstract

BACKGROUND

Uremic cardiomyopathy is commonly presented in chronic kidney disease (CKD), and it severely affects the prognosis of patients with CKD. In the past few decades, the investigation of uremic cardiomyopathy has developed rapidly. However, no report has summarized the situation of uremic cardiomyopathy research to date. This study aimed to evaluate the state of uremic cardiomyopathy research in the last 30 years and identify important topics and achievements, as well as emerging trends through bibliometric analysis.

MATERIALS AND METHODS

Publications related to uremic cardiomyopathy were collected from Science Citation Index Expanded. HistCite, VOSviewer, CiteSpace, and the Bibliometrix Package were used for bibliometric analysis and visualization, including the analysis of the overall distribution of the annual publication, leading countries, and active institutions and authors, core journals, co-cited references, and keywords.

RESULTS

A total of 2,403 studies related to uremic cardiomyopathy were obtained, and progress related to uremic cardiomyopathy was slower in past 3 years. A total of 10,077 authors from 2,697 institutions in 89 countries or regions reported investigations on uremic cardiomyopathy. The United States of America was the most productive and the most cited country. Myles Wolf, Joseph I Shapiro, and Carmine Zoccali published most articles in uremic cardiomyopathy, and journals in nephrology possessed core status in the field. Phosphate metabolism was the hotspot in uremic cardiomyopathy research in recent years, and future progress may concentrate on phosphate metabolism, endogenous natriuretic factors, and novel biomarkers.

CONCLUSION

The United States of America and European countries played central roles in uremic cardiomyopathy research, while Chinese scholars should be more involved in this field. Global publications on uremic cardiomyopathy have entered platform stage, and the fibroblast growth factor-23-klotho axis remained a hotspot in this field. Endogenous natriuretic factors and novel biomarkers may be potential directions in future investigations.

摘要

背景

尿毒症性心肌病常见于慢性肾脏病(CKD)患者,严重影响CKD患者的预后。在过去几十年中,尿毒症性心肌病的研究发展迅速。然而,迄今为止尚无报告总结尿毒症性心肌病的研究情况。本研究旨在通过文献计量分析评估过去30年尿毒症性心肌病的研究状况,确定重要主题和成果以及新出现的趋势。

材料与方法

从科学引文索引扩展版中收集与尿毒症性心肌病相关的出版物。使用HistCite、VOSviewer、CiteSpace和Bibliometrix软件包进行文献计量分析和可视化,包括年度出版物的总体分布、主要国家、活跃机构和作者、核心期刊、共被引参考文献以及关键词分析。

结果

共获得2403项与尿毒症性心肌病相关的研究,过去3年中与尿毒症性心肌病相关的进展较为缓慢。来自89个国家或地区2697个机构的10077名作者报告了对尿毒症性心肌病的研究。美国是产出最多且被引用最多的国家。迈尔斯·沃尔夫、约瑟夫·I·夏皮罗和卡尔米内·佐卡利发表的关于尿毒症性心肌病的文章最多,肾脏病领域的期刊在该领域具有核心地位。磷代谢是近年来尿毒症性心肌病研究的热点,未来进展可能集中在磷代谢、内源性利钠因子和新型生物标志物方面。

结论

美国和欧洲国家在尿毒症性心肌病研究中发挥了核心作用,而中国学者应更多地参与该领域。全球关于尿毒症性心肌病的出版物已进入平台期,成纤维细胞生长因子-23-klotho轴仍是该领域的热点。内源性利钠因子和新型生物标志物可能是未来研究的潜在方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d71f/9314665/7bba1a5b81ea/fcvm-09-908040-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验